Taiwan FDA registration 4993fde305a137086316dd8ac8cf3868

Imno Concester fluorescent autologous antinuclear antibody assay group

TW: 伊姆諾康塞斯特螢光自體抗核抗體測定組
Taiwan flagTaiwan·Risk Class 2·IMMUNO CONCEPTS NA LTD·Registered Jun 25, 2012 – Jun 25, 2017Cancelled
Registration details
Analysis ID
4993fde305a137086316dd8ac8cf3868
Customs Code
DHA00602366105
Company information
Manufacturer Country
United States
Authorized Representative
GRANT TECHNOLOGY CO., LTD.
Product details
Intended Use
Semi-quantitative determination of autologous antinuclear antibodies in human serum using an indirect fluorescent antibody assay.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.5100 抗核抗體免疫試驗系統
Import Information
import
Dates and status
Registration Date
Jun 25, 2012
Expiry Date
Jun 25, 2017
Cancellation Date
Nov 15, 2019
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
Companies making similar products

Top companies providing products similar to "Imno Concester fluorescent autologous antinuclear antibody assay group"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Imno Concester fluorescent autologous antinuclear antibody assay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4993fde305a137086316dd8ac8cf3868 and manufactured by IMMUNO CONCEPTS NA LTD. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including IMMUNO CONCEPTS NA LTD, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations